Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Pain 1Neoplasms 1Lymphoma, Follicular 1Kidney Neoplasms 1Emergencies 1Duodenal Neoplasms 1Acute Pain 1

Interventions

obeticholic acid 1fludarabine 1apixaban 1aldesleukin 1X-Rays 1Tea 1Surgical Procedures, Operative 1Specimen Handling 1Rivaroxaban 1Phantoms, Imaging 1Pantoprazole 1Iopamidol 1Hydromorphone 1High-Energy Shock Waves 1Endoscopy, Gastrointestinal 1Dalteparin 1Cyclophosphamide 1Bupivacaine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Duodenal Neoplasms × Hydromorphone × Clear all
NCT06411795 2026-02-03

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡